VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $446,634,000 | -69.4% | 4,393,848 | -46.3% | 1.61% | -68.3% |
| Q3 2015 | $1,458,538,000 | +284.2% | 8,176,586 | +378.5% | 5.07% | +314.0% |
| Q2 2015 | $379,597,000 | +65.3% | 1,708,746 | +47.8% | 1.22% | +78.7% |
| Q1 2015 | $229,588,000 | +53.9% | 1,155,927 | +10.9% | 0.68% | +70.4% |
| Q4 2014 | $149,149,000 | +4691.2% | 1,042,191 | +4296.5% | 0.40% | +4925.0% |
| Q3 2014 | $3,113,000 | -46.1% | 23,705 | -48.0% | 0.01% | -50.0% |
| Q2 2014 | $5,771,000 | -71.3% | 45,552 | -70.2% | 0.02% | -69.2% |
| Q1 2014 | $20,114,000 | -30.9% | 152,647 | -38.5% | 0.05% | -26.8% |
| Q4 2013 | $29,096,000 | -2.1% | 248,074 | -12.8% | 0.07% | -9.0% |
| Q3 2013 | $29,709,000 | +288.7% | 284,340 | +219.7% | 0.08% | +290.0% |
| Q2 2013 | $7,644,000 | – | 88,929 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |